ORCID as entered in ROS

Select Publications
2009, 'Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients', NDT Plus, 2, pp. 508, http://dx.doi.org/10.1093/ndtplus/sfp095
,2009, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD007554
,2008, 'Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics', Clinical Journal of the American Society of Nephrology, 3, pp. 1711 - 1717, http://dx.doi.org/10.2215/CJN.00190108
,2008, 'Phosphate balance on peritoneal dialysis', PERITONEAL DIALYSIS INTERNATIONAL, 28, pp. S26 - S32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257889700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Automated and continuous ambulatory peritoneal dialysis have similar outcomes', Kidney International, 73, pp. 480 - 488, http://dx.doi.org/10.1038/sj.ki.5002705
,2008, 'Treatment for peritoneal dialysis-associated peritonitis', COCHRANE DATABASE OF SYSTEMATIC REVIEWS, http://dx.doi.org/10.1002/14651858.CD005284.pub2
,2007, 'Does Sevelamer reduce mortality by slowing of progression of coronary calcification? [9]', Kidney International, 71, pp. 1328 - 1329, http://dx.doi.org/10.1038/sj.ki.5002316
,2006, 'Subjective global assessment of nutritional status of patients with chronic renal insufficiency and end stage renal disease on dialysis', Journal of Association of Physicians of India, 54, pp. 923 - 926
,2006, 'Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations', Nephrology Dialysis Transplantation, 21, pp. 776 - 783, http://dx.doi.org/10.1093/ndt/gfi248
,2005, 'Food for thought.', Annals of Internal Medicine, 143, pp. 149, http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00017
,2004, 'Severe muscle weakness due to hyperkalemia', Journal of Association of Physicians of India, 52, pp. 505 - 506
,2004, 'Acute renal tubular injury with acute hepatitis a infection: Is it just a coincidence?', Nephrology, 9, pp. 44 - 46, http://dx.doi.org/10.1111/j.1440-1797.2003.00224.x
,2003, 'Cytomegalovirus nasal polyp after renal transplant', Journal of Association of Physicians of India, 51, pp. 614 - 615
,'THE ASSOCIATION OF FUNCTIONAL STATUS WITH MORTALITY AND DIALYSIS MODALITY CHANGE: RESULTS FROM THE PERITONEAL DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (PDOPPS)', PERITONEAL DIALYSIS INTERNATIONAL, 39, pp. 103 - 111, http://dx.doi.org/10.3747/pdi.2018.00094
,2023, 'LONG-TERM SAFETY OF HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in NEPHROLOGY, WILEY, pp. 12 - 12
,2021, 'Urate-lowering Therapy for Prevention of Gout: Prespecified Analyses from the CKD-FIX Trial', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 1372 - 1373, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000744545202187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE KIDNEY FUNCTION: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000469797101164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, AUSTRIA, Vienna, pp. 413 - 413, presented at 53rd ERA-EDTA Congress, AUSTRIA, Vienna, 21 May 2016 - 24 May 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376653801474&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease', Vol. 32, pp. B9 - B9, http://dx.doi.org/10.1681/asn.20213210s1b9a
,2024, 'A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trial', in Journal of Vascular Access, Vol. 25, pp. 193 - 202, http://dx.doi.org/10.1177/11297298221099134
,2024, 'QUALITY OF CHRONIC KIDNEY DISEASE CARE IN AUSTRALIAN PRIMARY CARE: ANALYSIS OF A NATIONAL GENERAL PRACTICE DATASET', in NEPHROLOGY, WILEY, Vol. 29, pp. 13 - 13
,2022, 'Relationship Between Dietary Phosphate Intake and Biomarkers of Bone and Mineral Metabolism in Australian Adults With Chronic Kidney Disease', in Journal of Renal Nutrition, Vol. 32, pp. 58 - 67, http://dx.doi.org/10.1053/j.jrn.2021.07.004
,2022, 'PERIPHERAL BLOOD MITOCHONDRIAL DNA COPY NUMBER DOES NOT PREDICT THE SEVERITY OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)', in NEPHROLOGY, WILEY, Vol. 27, pp. 47 - 48
,2021, 'EFFECTS OF PHOSPHATE-LOWERING THERAPY IN NON-DIALYSIS CHRONIC KIDNEY DISEASE - A SYSTEMATIC REVIEW AND META-ANALYSES', in NEPHROLOGY, WILEY, Vol. 26, pp. 20 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000689277100051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'GLOMERULAR DISEASE REGISTRY AND BIOBANK (GRIT)', in NEPHROLOGY, WILEY, Vol. 25, pp. 50 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO ALBUMINURIA AT BASELINE: RESULTS FROM PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE SERUM URATE LEVEL: RESULTS FROM POST HOC ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO DIABETIC KIDNEY DISEASE AT BASELINE: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'VARIABILITY IN EGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE', in NEPHROLOGY, WILEY, Vol. 25, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'The effects of canagliflozin on uric acid and gout in patients with type 2 diabetes in the CANVAS programme', in DIABETOLOGIA, SPRINGER, SPAIN, Barcelona, Vol. 62, pp. S340 - S341, presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SPAIN, Barcelona, 16 September 2019 - 20 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303803039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'IMPROVING CARDIOVASCULAR OUTCOMES THROUGH PHOSPHATE LOWERING IN CKD? BASELINE CHARACTERISTICS OF PARTICIPANTS IN THE 'IMPACT OF PHOSPHATE REDUCTION ON VASCULAR END-POINTS IN CHRONIC KIDNEY DISEASE' (IMPROVE-CKD) STUDY', in NEPHROLOGY, WILEY, Vol. 23, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'RISK PREDICTORS AND CAUSES OF TECHNIQUE FAILURE WITHIN THE FIRST YEAR OF PERITONEAL DIALYSIS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, DENMARK, Copenhagen, Vol. 33, presented at 55th Congress of the European-Renal-Association (ERA) and European-Dialysis-and-Transplantation-Association (EDTA), DENMARK, Copenhagen, 24 May 2018 - 27 May 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000433059800530&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Trends in Long-Term Outcomes of Kidney Transplantation in Australia and New Zealand', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY, IL, Chicago, Vol. 17, pp. 795 - 796, presented at American Transplant Congress, IL, Chicago, 29 April 2017 - 03 May 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000404515704556&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'CARDIOVASCULAR BIOMARKERS, GLOBAL LEFT VENTRICULAR STRAIN, AND TOLERABILITY OF THE BETA-BLOCKER CARVEDILOL IN PATIENTS RECEIVING DIALYSIS', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 95 - 95, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383590600119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'EFFECT OF FISH OIL AND ASPIRIN ON ARTERIOVENOUS FISTULA FAILURE IN HAEMODIALYSIS - A RANDOMIZED CONTROLLED TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 47 - 47, http://dx.doi.org/10.1111/nep.12884
,2016, 'EFFECT OF THE BETA-BLOCKER CARVEDILOL ON BIOMARKERS OF CARDIOVASCULAR DISEASE IN PATIENTS RECEIVING DIALYSIS', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 94 - 94, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383590600117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES: A SYSTEMATIC REVIEWAND META-ANALYSIS', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 108 - 108, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383590600147&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2024, Effects of iron on cardiovascular, kidney and safety outcomes in patients with chronic kidney disease: a systematic review and meta-analysis, http://dx.doi.org/10.1101/2024.03.28.24305010
,2023, Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care, http://dx.doi.org/10.1101/2023.06.26.23291881
,2023, The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset, http://dx.doi.org/10.1101/2023.06.18.23290762
,Effect of Urate-Lowering Therapy on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis, http://dx.doi.org/10.2139/ssrn.3506167
,